The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $45.98

Today's change+0.38 +0.82%
Updated May 6 3:46 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $45.98

Today's change+0.38 +0.82%
Updated May 6 3:46 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC crosses above 125-day moving average

GlaxoSmithKline PLC closed up Wednesday by (U.S.)$0.38 or 0.82% to (U.S.)$45.98 and crossing above its 125-day moving average. Shares have lost 1.74% over the last five days, but have gained 7.57% over the last year to date. This security has underperformed the S&P 500 by 28.14% during the last year.

Key company metrics

  • Open(U.S.) $46.74
  • Previous close(U.S.) $45.60
  • High(U.S.) $46.76
  • Low(U.S.) $45.81
  • Bid / Ask(U.S.) $45.97 / (U.S.) $45.98
  • YTD % change+7.57%
  • Volume6,496,540
  • Average volume (10-day)4,075,127
  • Average volume (1-month)3,285,007
  • Average volume (3-month)3,459,032
  • 52-week range(U.S.) $41.25 to (U.S.) $55.63
  • Beta0.59
  • Trailing P/E26.74×
  • P/E 1 year forward16.72×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.60
  • Dividend yield5.65%
  • Trailing EPS(U.S.) $1.72
Updated May 6 3:46 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.31%

Based on its net profit margin of 12.31%, GlaxoSmithKline PLC is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.15%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue6,1865,6465,5615,613
Total other revenue--------
Total revenue6,1865,6465,5615,613
Gross profit4,2783,8943,8883,908
Total cost of revenue1,9081,7521,6731,705
Total operating expense5,4954,9434,4244,547
Selling / general / administrative1,9391,7951,9691,919
Research & development821742766784
Depreciation / amortization15171723
Interest expense (income), net operating--------
Unusual expense (income)53273871186
Other operating expenses, total280-101-72-70
Operating income6917031,1371,066
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax531548986903
Income after tax1,025385702719
Income tax, total-494163284184
Net income1,033401654668
Total adjustments to net income--------
Net income before extra. items1,033401654668
Minority interest816-48-51
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,033401654668
Inc. avail. to common incl. extra. items1,033401654668
Diluted net income1,033401654668
Dilution adjustment--------
Diluted weighted average shares4,8114,8654,8744,866
Diluted EPS excluding extraordinary itemsvalue per share0.210.080.130.14
Dividends per sharevalue per share0.230.190.190.19
Diluted normalized EPSvalue per share0.190.210.160.17